Skip to main content

and
  1. Article

    Open Access

    EZH2 inhibitors promote β-like cell regeneration in young and adult type 1 diabetes donors

    β-cells are a type of endocrine cell found in pancreatic islets that synthesize, store and release insulin. In type 1 diabetes (T1D), T-cells of the immune system selectively destroy the insulin-producing β-ce...

    Keith Al-Hasani, Safiya Naina Marikar in Signal Transduction and Targeted Therapy (2024)

  2. Article

    Open Access

    Pharmacological inhibition of human EZH2 can influence a regenerative β-like cell capacity with in vitro insulin release in pancreatic ductal cells

    Therapeutic replacement of pancreatic endocrine β-cells is key to improving hyperglycaemia caused by insulin-dependent diabetes . Whilst the pool of ductal progenitors, which give rise to the endocrine cells, ...

    Safiya Naina Marikar, Keith Al-Hasani, Ishant Khurana in Clinical Epigenetics (2023)

  3. Article

    Open Access

    Inhibition of pancreatic EZH2 restores progenitor insulin in T1D donor

    Type 1 diabetes (T1D) is an autoimmune disease that selectively destroys insulin-producing β-cells in the pancreas. An unmet need in diabetes management, current therapy is focussed on transplantation. While t...

    Keith Al-Hasani, Ishant Khurana, Lina Mariana in Signal Transduction and Targeted Therapy (2022)

  4. Article

    Open Access

    Microencapsulation-based cell therapies

    Map** a new therapeutic route can be fraught with challenges, but recent developments in the preparation and properties of small particles combined with significant improvements to tried and tested technique...

    Safiya Naina Marikar, Assam El-Osta, Angus Johnston in Cellular and Molecular Life Sciences (2022)

  5. Article

    Open Access

    SAHA attenuates Takotsubo-like myocardial injury by targeting an epigenetic Ac/Dc axis

    Ishant Khurana, Scott Maxwell, Simon Royce in Signal Transduction and Targeted Therapy (2021)

  6. Article

    Open Access

    Epigenetic evidence of an Ac/Dc axis by VPA and SAHA

    Valproic acid (VPA) is one of the most commonly used anti-epileptic drugs with pharmacological actions on GABA and blocking voltage-gated ion channels. VPA also inhibits histone deacetylase (HDAC) activity. Su...

    Sebastian Lunke, Scott Maxwell, Ishant Khurana, Harikrishnan K.N. in Clinical Epigenetics (2021)

  7. Article

    Open Access

    DNA methylation status correlates with adult β-cell regeneration capacity

    The role of DNA methylation in β-cell neogenesis is poorly understood. We report that during the process of induced cell reprogramming, methylation content of the Ngn3 and Sox11 genes are diminished. These findin...

    Ishant Khurana, Keith Al-Hasani, Scott Maxwell in npj Regenerative Medicine (2021)

  8. Article

    Open Access

    Valproic acid influences the expression of genes implicated with hyperglycaemia-induced complement and coagulation pathways

    Because the liver plays a major role in metabolic homeostasis and secretion of clotting factors and inflammatory innate immune proteins, there is interest in understanding the mechanisms of hepatic cell activa...

    Marina Barreto Felisbino, Mark Ziemann, Ishant Khurana, Jun Okabe in Scientific Reports (2021)

  9. Article

    Open Access

    Human Aurora kinase inhibitor Hesperadin reveals epistatic interaction between Plasmodium falciparum PfArk1 and PfNek1 kinases

    Mitosis has been validated by numerous anti-cancer drugs as being a druggable process, and selective inhibition of parasite proliferation provides an obvious opportunity for therapeutic intervention against ma...

    Belinda J. Morahan, Clarissa Abrie, Keith Al-Hasani in Communications Biology (2020)

  10. No Access

    Article

    Determinants of Proteolysis and Cell-Binding for the Shigella flexneri Cytotoxin, SigA

    Shigella flexneri secretes an enterotoxic, SPATE family autotransporter (AT), SigA, which has cytopathic activity towards cultured epithelial cells. Its cytopathic activity is due to its ...

    Eng Guan Chua, Keith Al-Hasani, Martin Scanlon, Ben Adler in Current Microbiology (2015)

  11. No Access

    Article

    Genome sequence and identification of candidate vaccine antigens from the animal pathogen Dichelobacter nodosus

    Dichelobacter nodosus causes ovine footrot, a disease that leads to severe economic losses in the wool and meat industries. We sequenced its 1.4-Mb genome, the smallest known genome of an anaerobe. It differs mar...

    Garry S A Myers, Dane Parker, Keith Al-Hasani, Ruth M Kennan in Nature Biotechnology (2007)

  12. Article

    Open Access

    Identification of novel immunogens in Pasteurella multocida

    P. multocida is a Gram-negative pathogen responsible for causing diseases in animals of economic significance to livestock industries throughout the world. Current vaccines include bacterins, which provide only l...

    Keith Al-Hasani, John Boyce, Victoria P McCarl in Microbial Cell Factories (2007)

  13. Article

    Open Access

    Genomic and proteomics approaches for vaccine development in Pasteurella multocida

    Keith Al-Hasani, Victoria McCarl, Stephen Bottomley, Ben Adler in Microbial Cell Factories (2006)

  14. No Access

    Article

    A 191-kb genomic fragment containing the human α-globin locus can rescue α-thalassemic mice

    A 191-kb human bacterial artificial chromosome (BAC) containing the human α-globin genomic locus was used to generate transgenic mice that express, exclusively, human α-globin (huα-globin). Expression of huα-glob...

    Keith Al-Hasani, Jim Vadolas, Anja S. Knaupp, Hady Wardan in Mammalian Genome (2005)

  15. No Access

    Article

    Complementation of α-thalassaemia in α-globin Knockout Mice with a 191 kb Transgene Containing the Human α-Globin Locus

    α-Thalassaemia is an inherited blood disorder caused by a decrease in the synthesis of α-globin due to mutations in one or both of the α-globin genes located on human chromosome 16. A 191 kb transgene derived ...

    Keith Al-Hasani, Jim Vadolas, Lucille Voullaire, Robert Williamson in Transgenic Research (2004)